Oncology

Latest News

EOP thumbnail
Eye on Pharma: Henlius, Organon Updates; Meitheal Portfolio Expansion; Celltrion Zymfentra Data

November 5th 2024

Henlius and Organon’s pertuzumab biosimilar met phase 3 goals; Meitheal expanded its US biosimilars; Celltrion’s subcutaneous infliximab (Zymfentra) showed monotherapy could be as effective as combination therapy for inflammatory bowel disease.

data rising | Image credit: Suriya - stock.adobe.com
Samsung Bioepis Report Showcases Adalimumab Biosimilar Growth in Market Share

October 11th 2024

dna and syringe for CGTs | Image credit: natali_mis - stock.adobe.com
Duke Publishes Recommendations for Developing CGT Biosimilars

October 9th 2024

inflation reduction act | Image credit: wladimir1804 - stock.adobe.com
IRA Reimbursement Impact on Biosimilars Minimal Despite Rising Market Share

September 25th 2024

Breast cancer research. | Image Credit:  shidlovski - stock.adobe.com
Trastuzumab Biosimilar and Pertuzumab Effective, Safe in Neoadjuvant Breast Cancer Therapy

September 19th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.